CATALYST FINANCIAL PARTNERS LLC

Position in ABT — Abbott Laboratories

CIK 1927537 BOSTON, MA

Position in ABT

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$970,555

-$297,624 QoQ

Shares Held

10,696

-13.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#1,507

of 2,959 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $9,789,819 across 6 Medical Devices names. ABT ranks #2 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UFPT	Ufp Technologies Inc	26,457	$7,014,544
2	ABT	Abbott Laboratories This page	10,696	$970,555
3	SYK	Stryker Corp	1,904	$599,455
4	MDT	Medtronic plc	6,711	$525,001
5	BSX	Boston Scientific Corp	8,760	$373,876
6	EW	Edwards Lifesciences Corp	3,387	$306,388

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$970,555	10,696	-13.4%	Shares	Sole	2026-07-30
2026-03-31	$1,268,179	12,352	+40.6%	Shares	Sole	2026-05-12
2025-12-31	$1,100,422	8,783	-4.0%	Shares	Sole	2026-02-04
2025-09-30	$1,224,881	9,145	+2.5%	Shares	Sole	2025-11-12
2025-06-30	$1,213,481	8,922	+7.1%	Shares	Sole	2025-08-14
2025-03-31	$1,105,239	8,332	+5.0%	Shares	Sole	2025-05-02
2024-12-31	$897,640	7,936	+4.5%	Shares	Sole	2025-01-30
2024-09-30	$865,905	7,595	+10.7%	Shares	Sole	2024-10-28
2024-06-30	$713,030	6,862	+1.3%	Shares	Sole	2024-07-25
2024-03-31	$769,932	6,774	+8.1%	Shares	Sole	2024-04-23
2023-12-31	$689,808	6,267	+6.7%	Shares	Sole	2024-02-07
2023-09-30	$568,800	5,873	+16.1%	Shares	Sole	2023-10-26
2023-06-30	$551,314	5,057	+10.5%	Shares	Sole	2023-08-02
2023-03-31	$463,365	4,576	+7.9%	Shares	Sole	2023-04-11
2022-12-31	$465,619	4,241	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.